elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Positron Emission Tomography-Computed Tomography
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Positron Emission Tomography-Computed Tomography
RIS
0.001
(Research Intensity Score)
Papers
74
Top papers
Accuracy of Gallium-68 Pentixafor Positron Emission Tomography–Computed Tomography for Subtyping Diagnosis of Primary Aldosteronism
2023 · 116 citations
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
2025 · 26 citations
Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
2020 · 209 citations
Transforming [ 177 Lu]Lu‐PSMA‐617 treatment planning: Machine learning‐based radiodosiomics and swin UNETR using pretherapy PSMA positron emission tomography/computed tomography (PET/CT)
2025 · 10 citations
First clinical experience with single-photon emission computed tomography with technetium-99m-labeled prostate-specific membrane antigen at the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine
2026
Diagnostic Value of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Staging Histological Subtypes of Invasive Bladder Cancer
2026 · 1 citations
[68Ga]Ga-DOTA-TOC positron emission tomography outperforms [18F]FDOPA and [18F]FDG PET in pediatric neuroblastoma imaging: a prospective study
2025 · 4 citations
PSMA expression and PSMA PET/CT imaging in metastatic soft tissue sarcoma patients, results of a prospective study
2025 · 5 citations
The Current Landscape of Prostate-Specific Membrane Antigen (PSMA) Imaging Biomarkers for Aggressive Prostate Cancer
2024 · 14 citations
Newest papers
First clinical experience with single-photon emission computed tomography with technetium-99m-labeled prostate-specific membrane antigen at the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine
2026
Diagnostic Value of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Staging Histological Subtypes of Invasive Bladder Cancer
2026 · 1 citations
Optimization of Administered Activity for 64Cu-SAR-bisPSMA PET Imaging in Primary Prostate Cancer: Results from a Phase I Retrospective Study (PROPELLER Sub-study)
2026
Dual‑targeted radioligand therapy with [177Lu]Lu‑DOTATATE plus [177Lu]Lu‑DOTA‑IBA for bone metastases from neuroendocrine neoplasms: a prospective pilot study
2026
Single photon emission computed tomography/computed tomography clue to pulmonary metastasis in osteosarcoma: a diagnostic pitfall of technetium-99m methylene diphosphonate uptake
2026
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
2025 · 26 citations
Transforming [ 177 Lu]Lu‐PSMA‐617 treatment planning: Machine learning‐based radiodosiomics and swin UNETR using pretherapy PSMA positron emission tomography/computed tomography (PET/CT)
2025 · 10 citations
[68Ga]Ga-DOTA-TOC positron emission tomography outperforms [18F]FDOPA and [18F]FDG PET in pediatric neuroblastoma imaging: a prospective study
2025 · 4 citations
PSMA expression and PSMA PET/CT imaging in metastatic soft tissue sarcoma patients, results of a prospective study
2025 · 5 citations
Browse all papers →
Positron Emission Tomography-Computed Tomography's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Positron Emission Tomography-Computed Tomography's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link